The epidemiology and risk factors of inflammatory bowel disease

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 12, 2015, Pages 22529-22542

  Ye, Yulan ^a   Pang, Zhi ^a   Chen, Weichang ^b   Ju, Songwen ^a   Zhou, Chunli ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Environmental factors; Incidence; Inflammatory bowel disease; Morality; Prevalence

Indexed keywords

ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT;

APPENDECTOMY; BACTERIAL INFECTION; CAMPYLOBACTER; CLINICAL TRIAL (TOPIC); ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; HELICOBACTER PYLORI; HUMAN; HYGIENE HYPOTHESIS; IATROGENIC DISEASE; INFLAMMATORY BOWEL DISEASE; LIFESTYLE; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY (TOPIC); NUTRITION; POPULATION MIGRATION; REVIEW; RISK FACTOR; SALMONELLA; SMOKING; STRESS; SYSTEMATIC REVIEW (TOPIC);

EID: 84957108296     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. Pierik M, Yang H, Barmada MM, Cavanaugh JA, Annese V, Brant SR, Cho JH, Duerr RH, Hugot JP, McGovern DP, Paavola-Sakki P, Radford-Smith GL, Pavli P, Silverberg MS, Schreiber S, Taylor KD and Vlietinck R. The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. Inflamm Bowel Dis 2005; 11: 1-7.
2. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hugot JP, de Vos M, Vermeire S, Louis E, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwilliam R, Tremelling M, Deloukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M and Daly MJ. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 2008; 40: 955-962.
3. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517.
4. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW and Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54, e42; quiz e30.
5. Rogers BH, Clark LM and Kirsner JB. The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis 1971; 24: 743-773.
6. Mir-Madjlessi SH, Michener WM and Farmer RG. Course and prognosis of idiopathic ulcerative proctosigmoiditis in young patients. J Pediatr Gastroenterol Nutr 1986; 5: 571-575.
7. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J and Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011; 17: 423-439.
8. Benchimol EI, Guttmann A, Griffiths AM, Rabeneck L, Mack DR, Brill H, Howard J, Guan J and To T. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut 2009; 58: 1490-1497.
9. M’Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol 2013; 6: 33-47.
10. Leddin D, Tamim H and Levy AR. Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study. BMC Gastroenterol 2014; 14: 140.
11. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B, Lee NS and Niyonsenga T. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007; 357: 135-142.
12. Agoda-Koussema LK, Anoukoum T, Djibril AM, Balaka A, Folligan K, Adjenou V, Amouzou KD, N’Dakena K and Redah R. [Ulcerative colitis: a case in Togo]. Med Sante Trop 2012; 22: 79-81.
13. Mebazaa A, Aounallah A, Naija N, Cheikh Rouhou R, Kallel L, El Euch D, Boubaker J, Mokni M, Filali A and Ben Osman A. Dermatologic manifestations in inflammatory bowel disease in Tunisia. Tunis Med 2012; 90: 252-257.
14. Senbanjo IO, Oshikoya KA, Onyekwere CA, Abdulkareem FB and Njokanma OF. Ulcerative colitis in a Nigerian girl: a case report. BMC Res Notes 2012; 5: 564.
15. Wright JP, Marks IN, Jameson C, Garisch JA, Burns DG and Kottler RE. Inflammatory bowel disease in Cape Town, 1975-1980. Part II. Crohn’s disease. S Afr Med J 1983; 63: 226-229.
16. Novis BH, Marks IN, Bank S and Louw JH. Incidence of Crohn’s disease at Groote Schuur Hospital during 1970-1974. S Afr Med J 1975; 49: 693-697.
17. Sobel JD and Schamroth L. Ulcerative colitis in the South African Bantu. Gut 1970; 11: 760-763.
18. Giraud RM, Luke I and Schmaman A. Crohn’s disease in the Transvaal Bantu: a report of 5 cases. S Afr Med J 1969; 43: 610-613.
19. Segal I, Tim LO, Hamilton DG and Walker AR. The rarity of ulcerative colitis in South African blacks. Am J Gastroenterol 1980; 74: 332-336.
20. Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH, Li MF, Ng KK, Kamm MA, Studd C, Bell S, Leong R, de Silva HJ, Kasturiratne A, Mufeena MN, Ling KL, Ooi CJ, Tan PS, Ong D, Goh KL, Hilmi I, Pisespongsa P, Manatsathit S, Rerknimitr R, Aniwan S, Wang YF, Ouyang Q, Zeng Z, Zhu Z, Chen MH, Hu PJ, Wu K, Wang X, Simadibrata M, Abdullah M, Wu JC, Sung JJ, Chan FK, Asia-Pacific Cs and Colitis Epidemiologic Study Study G. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology 2013; 145: 158-165 e152.
21. Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, Winter HS, Fain P, King C, Smith T and El-Serag HB. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr 2005; 146: 35-40.
22. Ponder A and Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol 2013; 5: 237-247.
23. Russel MG. Changes in the incidence of inflammatory bowel disease: what does it mean? Eur J Intern Med 2000; 11: 191-196.
24. Pappa HM, Semrin G, Walker TR and Grand RJ. Pediatric inflammatory bowel disease. Curr Opin Gastroenterol 2004; 20: 333-340.
25. Hait E, Bousvaros A and Grand R. Pediatric inflammatory bowel disease: what children can teach adults. Inflamm Bowel Dis 2005; 11: 519-527.
26. Murch SH, Baldassano R, Buller H, Chin S, Griffiths AM, Hildebrand H, Jasinsky C, Kong T, Moore D, Orsi M, Commonwealth Association of Paediatric G and Nutrition. Inflammatory bowel disease: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39 Suppl 2: S647-654.
27. Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, Weisdorf-Schindele S, San Pablo W Jr, Perrault J, Park R, Yaffe M, Brown C, Rivera-Bennett MT, Halabi I, Martinez A, Blank E, Werlin SL, Rudolph CD, Binion DG and Wisconsin Pediatric Inflammatory Bowel Disease A. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003; 143: 525-531.
28. Henderson P, Hansen R, Cameron FL, Gerasimidis K, Rogers P, Bisset WM, Reynish EL, Drummond HE, Anderson NH, Van Limbergen J, Russell RK, Satsangi J and Wilson DC. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis 2012; 18: 999-1005.
29. Hildebrand H, Finkel Y, Grahnquist L, Lindholm J, Ekbom A and Askling J. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut 2003; 52: 1432-1434.
30. Perminow G, Frigessi A, Rydning A, Nakstad B and Vatn MH. Incidence and clinical presentation of IBD in children: comparison between prospective and retrospective data in a selected Norwegian population. Scand J Gastroenterol 2006; 41: 1433-1439.
31. Naidoo CM, Leach ST, Day AS and Lemberg DA. Inflammatory bowel disease in children of middle eastern descent. Int J Pediatr 2014; 2014: 906128.
32. Bernstein CN and Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008; 57: 1185-1191.
33. Probert CS, Jayanthi V, Pinder D, Wicks AC and Mayberry JF. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992; 33: 687-693.
34. Probert CS, Jayanthi V, Hughes AO, Thompson JR, Wicks AC and Mayberry JF. Prevalence and family risk of ulcerative colitis and Crohn’s disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 1993; 34: 1547-1551.
35. Carr I and Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first-and secondgeneration South Asians in Leicester (1991-1994). Am J Gastroenterol 1999; 94: 2918-2922.
36. Li X, Sundquist J, Hemminki K and Sundquist K. Risk of inflammatory bowel disease in firstand second-generation immigrants in Sweden: a nationwide follow-up study. Inflamm Bowel Dis 2011; 17: 1784-1791.
37. Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA and Jacobson K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 2007; 102: 1077-1083.
38. Benchimol EI, Mack DR, Guttmann A, Nguyen GC, To T, Mojaverian N, Quach P and Manuel DG. Inflammatory bowel disease in immigrants to Canada and their children: a populationbased cohort study. Am J Gastroenterol 2015; 110: 553-563.
39. Benchimol EI, Manuel DG, To T, Mack DR, Nguyen GC, Gommerman JL, Croitoru K, Mojaverian N, Wang X, Quach P and Guttmann A. Asthma, type 1 and type 2 diabetes mellitus, and inflammatory bowel disease amongst South Asian immigrants to Canada and their children: a population-based cohort study. PLoS One 2015; 10: e0123599.
40. Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P and Jess T. Overall and causespecific mortality in Crohn’s disease: a metaanalysis of population-based studies. Inflamm Bowel Dis 2010; 16: 347-353.
41. Jess T, Gamborg M, Munkholm P and Sorensen TI. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of populationbased inception cohort studies. Am J Gastroenterol 2007; 102: 609-617.
42. Jess T, Frisch M and Simonsen J. Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol 2013; 11: 43-48.
43. Bewtra M, Kaiser LM, TenHave T and Lewis JD. Crohn’s disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis 2013; 19: 599-613.
44. Ananthakrishnan AN, Cagan A, Gainer VS, Cheng SC, Cai T, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I and Liao KP. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease. J Crohns Colitis 2014; 8: 956-963.
45. Kassam Z, Belga S, Roifman I, Hirota S, Jijon H, Kaplan GG, Ghosh S and Beck PL. Inflammatory bowel disease cause-specific mortality: a primer for clinicians. Inflamm Bowel Dis 2014; 20: 2483-2492.
46. Harries AD, Baird A and Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982; 284: 706.
47. Mahid SS, Minor KS, Soto RE, Hornung CA and Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006; 81: 1462-1471.
48. Biedermann L, Fournier N, Misselwitz B, Frei P, Zeitz J, Manser CN, Pittet V, Juillerat P, von Kaenel R, Fried M, Vavricka S and Rogler G. High rates of smoking especially in female Crohn’s disease patients and low use of supportive measures to achieve smoking cessation-Data from the SwissIBD cohort study. J Crohns Colitis 2015; 9: 819-29.
49. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841-1854.
50. Rubin DT and Hanauer SB. Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000; 12: 855-862.
51. Boyko EJ, Koepsell TD, Perera DR and Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987; 316: 707-710.
52. Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A and Fuchs CS. A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol 2012; 107: 1399-1406.
53. Cosnes J, Nion-Larmurier I, Afchain P, Beaugerie L and Gendre JP. Gender differences in the response of colitis to smoking. Clin Gastroenterol Hepatol 2004; 2: 41-48.
54. Lakatos PL, Szamosi T and Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 2007; 13: 6134-6139.
55. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004; 18: 481-496.
56. Richardson CE, Morgan JM, Jasani B, Green JT, Rhodes J, Williams GT, Lindstrom J, Wonnacott S, Peel S and Thomas GA. Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. QJM 2003; 96: 57-65.
57. Razani-Boroujerdi S, Boyd RT, Davila-Garcia MI, Nandi JS, Mishra NC, Singh SP, Pena-Philippides JC, Langley R and Sopori ML. T cells express alpha7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response. J Immunol 2007; 179: 2889-2898.
58. Birrenbach T and Bocker U. Inflammatory bowel disease and smoking: a review of epidemiol ogy, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004; 10: 848-859.
59. Sher ME, Bank S, Greenberg R, Sardinha TC, Weissman S, Bailey B, Gilliland R and Wexner SD. The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease. Inflamm Bowel Dis 1999; 5: 73-78.
60. Miller LG, Goldstein G, Murphy M and Ginns LC. Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest 1982; 82: 526-529.
61. Allais L, Kerckhof FM, Verschuere S, Bracke KR, De Smet R, Laukens D, Van den Abbeele P, De Vos M, Boon N, Brusselle GG, Cuvelier CA and Van de Wiele T. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol 2015; [Epub ahead of print].
62. Sawyerr AM, Wakefield AJ, Hudson M, Dhillon AP and Pounder RE. Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn’s disease. Aliment Pharmacol Ther 1991; 5: 1-14.
63. Biedermann L, Brulisauer K, Zeitz J, Frei P, Scharl M, Vavricka SR, Fried M, Loessner MJ, Rogler G and Schuppler M. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm Bowel Dis 2014; 20: 1496-1501.
64. Munyaka PM, Khafipour E and Ghia JE. External influence of early childhood establishment of gut microbiota and subsequent health implications. Front Pediatr 2014; 2: 109.
65. Shields M. Smoking bans: influence on smoking prevalence. Health Rep 2007; 18: 9-24.
66. Bernstein CN, Rawsthorne P, Cheang M and Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol 2006; 101: 993-1002.
67. Ouyang Q, Tandon R, Goh KL, Ooi CJ, Ogata H and Fiocchi C. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol 2005; 21: 408-413.
68. Gent AE, Hellier MD, Grace RH, Swarbrick ET and Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766-767.
69. Koloski NA, Bret L and Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol 2008; 14: 165-173.
70. Lashner BA and Loftus EV Jr. True or false? The hygiene hypothesis for Crohn’s disease. Am J Gastroenterol 2006; 101: 1003-1004.
71. Amre DK, Lambrette P, Law L, Krupoves A, Chotard V, Costea F, Grimard G, Israel D, Mack D and Seidman EG. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn’s disease: a case-control study. Am J Gastroenterol 2006; 101: 1005-1011.
72. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D and Blanchard JF. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006; 101: 1559-1568.
73. Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A and Colombel JF. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 2005; 54: 357-363.
74. Montgomery SM, Lambe M, Wakefield AJ, Pounder RE and Ekbom A. Siblings and the risk of inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 1301-1308.
75. Hampe J, Heymann K, Krawczak M and Schreiber S. Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure. Int J Colorectal Dis 2003; 18: 413-417.
76. Powell JJ, Harvey RS, Ashwood P, Wolstencroft R, Gershwin ME and Thompson RP. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun 2000; 14: 99-105.
77. Carpio D, Barreiro-de Acosta M, Echarri A, Pereira S, Castro J, Ferreiro R, Lorenzo A and Group E. Influence of urban/rural and coastal/ inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study. Eur J Gastroenterol Hepatol 2015; 27: 1030-7
78. Malekzadeh F, Alberti C, Nouraei M, Vahedi H, Zaccaria I, Meinzer U, Nasseri-Moghaddam S, Sotoudehmanesh R, Momenzadeh S, Khaleghnejad R, Rashtak S, Olfati G, Malekzadeh R and Hugot JP. Crohn’s disease and early exposure to domestic refrigeration. PLoS One 2009; 4: e4288.
79. Declercq C, Gower-Rousseau C, Vernier-Massouille G, Salleron J, Balde M, Poirier G, Lerebours E, Dupas JL, Merle V, Marti R, Duhamel A, Cortot A, Salomez JL and Colombel JF. Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence. Inflamm Bowel Dis 2010; 16: 807-812.
80. Feller M, Huwiler K, Stephan R, Altpeter E, Shang A, Furrer H, Pfyffer GE, Jemmi T, Baumgartner A and Egger M. Mycobacterium avium subspecies paratuberculosis and Crohn’s disease: a systematic review and meta-analysis. Lancet Infect Dis 2007; 7: 607-613.
81. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A and Colombel JF. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology 1998; 115: 1405-1413.
82. O’Brien CL, Pavli P, Gordon DM and Allison GE. Detection of bacterial DNA in lymph nodes of Crohn’s disease patients using high throughput sequencing. Gut 2014; 63: 1596-1606.
83. Cartun RW, Van Kruiningen HJ, Pedersen CA and Berman MM. An immunocytochemical search for infectious agents in Crohn’s disease. Mod Pathol 1993; 6: 212-219.
84. Tabaqchali S, O’Donoghue DP and Bettelheim KA. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 1978; 19: 108-113.
85. Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF and Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn’s disease survive and replicate within macrophages without inducing host cell death. Infect Immun 2001; 69: 5529-5537.
86. Nguyen HT, Dalmasso G, Muller S, Carriere J, Seibold F and Darfeuille-Michaud A. Crohn’s disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology 2014; 146: 508-519.
87. Nazareth N, Magro F, Machado E, Ribeiro TG, Martinho A, Rodrigues P, Alves R, Macedo GN, Gracio D, Coelho R, Abreu C, Appelberg R, Dias C, Macedo G, Bull T and Sarmento A. Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease. Med Microbiol Immunol 2015; 204: 681-92.
88. Luther J, Dave M, Higgins PD and Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 2010; 16: 1077-1084.
89. Wu XW, Ji HZ, Yang MF, Wu L and Wang FY. Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol 2015; 21: 4750-4756.
90. Ng SC, Woodrow S, Patel N, Subhani J and Harbord M. Role of genetic and environmental factors in British twins with inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 725-736.
91. Sipponen T, Turunen U, Lautenschlager I, Nieminen U, Arola J and Halme L. Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease. Scand J Gastroenterol 2011; 46: 1324-1333.
92. Linton MS, Kroeker K, Fedorak D, Dieleman L and Fedorak RN. Prevalence of Epstein-Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study. Aliment Pharmacol Ther 2013; 38: 1248-1254.
93. Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE and Korzenik J. The risk of developing Crohn’s disease after an appendectomy: a meta-analysis. Am J Gastroenterol 2008; 103: 2925-2931.
94. Andersson RE, Olaison G, Tysk C and Ekbom A. Appendectomy is followed by increased risk of Crohn’s disease. Gastroenterology 2003; 124: 40-46.
95. Radford-Smith GL. What is the importance of appendectomy in the natural history of IBD? Inflamm Bowel Dis 2008; 14 Suppl 2: S72-74.
96. Radford-Smith GL, Edwards JE, Purdie DM, Pandeya N, Watson M, Martin NG, Green A, Newman B and Florin TH. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn’s disease. Gut 2002; 51: 808-813.
97. Kurina LM, Goldacre MJ, Yeates D and Seagroatt V. Appendicectomy, tonsillectomy, and inflammatory bowel disease: a case-control record linkage study. J Epidemiol Community Health 2002; 56: 551-554.
98. Koutroubakis IE and Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol 2000; 95: 171-176.
99. Koutroubakis IE, Vlachonikolis IG and Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 2002; 8: 277-286.
100. Vcev A, Pezerovic D, Jovanovic Z, Nakic D, Vcev I and Majnaric L. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010. Wien Klin Wochenschr 2015; 127: 345-354.
101. Mayer L and Eisenhardt D. Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. J Clin Invest 1990; 86: 1255-1260.
102. Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP and Gleim G. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol 2000; 95: 1949-1954.
103. Kvasnovsky CL, Aujla U and Bjarnason I. Nonsteroidal anti-inflammatory drugs and exacer bations of inflammatory bowel disease. Scand J Gastroenterol 2015; 50: 255-263.
104. Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, Pamukcu R, Moore S and Lynch RG. Rapid development of colitis in NSAIDtreated IL-10-deficient mice. Gastroenterology 2002; 123: 1527-1542.
105. Cornish JA, Tan E, Simillis C, Clark SK, Teare J and Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008; 103: 2394-2400.
106. Timmer A, Sutherland LR and Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn’s disease. The Canadian Mesalamine for Remission of Crohn’s Disease Study Group. Gastroenterology 1998; 114: 1143-1150.
107. Hildebrand H, Malmborg P, Askling J, Ekbom A and Montgomery SM. Early-life exposures associated with antibiotic use and risk of subsequent Crohn’s disease. Scand J Gastroenterol 2008; 43: 961-966.
108. Hviid A, Svanstrom H and Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011; 60: 49-54.
109. Hou JK, Abraham B and El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011; 106: 563-573.
110. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Willett WC, Richter JM and Chan AT. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut 2014; 63: 776-784.
111. Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonova O, Vind I, Avnstrom S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Bjornsson E, Bailey Y, O’Morain C, Schwartz D, Odes S, Giannotta M, Girardin G, Kiudelis G, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Martinez-Ares D, Hernandez V, Almer S, Zhulina Y, Halfvarson J, Arebi N, Tsai HH, Sebastian S, Lakatos PL, Langholz E and Munkholm P. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe-an ECCO-EpiCom study. J Crohns Colitis 2014; 8: 607-616.
112. Amre DK, D’Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, Israel D, Mack D, Ghadirian P, Deslandres C, Chotard V, Budai B, Law L, Levy E and Seidman EG. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn’s disease in children. Am J Gastroenterol 2007; 102: 2016-2025.
113. Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrugger RW and Brummer RJ. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000; 95: 1008-1013.
114. Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, Feng L, Lee WH, Fitzgerald KA and Hwang DH. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004; 279: 16971-16979.
115. Devkota S and Chang EB. Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases. Dig Dis 2015; 33: 351-356.
116. Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T, Inaba Y, Miyake Y, Sasaki S, Okamoto K, Kobashi G, Washio M, Yokoyama T, Date C, Tanaka H and Epidemiology Group of the Research Committee on Inflammatory Bowel Disease in J. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005; 11: 154-163.
117. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM and Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology 2013; 145: 970-977.
118. Li F, Liu X, Wang W and Zhang D. Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis. Eur J Gastroenterol Hepatol 2015; 27: 623-630.
119. Galvez J, Rodriguez-Cabezas ME and Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res 2005; 49: 601-608.
120. Cantorna MT and Mahon BD. D-hormone and the immune system. J Rheumatol Suppl 2005; 76: 11-20.
121. Cantorna MT and Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004; 229: 1136-1142.
122. Mouli VP and Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39: 125-136.
123. Froicu M and Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 2007; 8: 5.
124. Veit LE, Maranda L and Nwosu BU. The nondietary determinants of vitamin D status in pediatric inflammatory bowel disease. Nutrition 2015; 31: 994-999.
125. Maunder RG and Levenstein S. The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence. Curr Mol Med 2008; 8: 247-252.
126. Mawdsley JE and Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 2005; 54: 1481-1491.
127. Sajadinejad MS, Asgari K, Molavi H, Kalantari M and Adibi P. Psychological issues in inflammatory bowel disease: an overview. Gastroenterol Res Pract 2012; 2012: 106502.
128. Goyal RK and Hirano I. The enteric nervous system. N Engl J Med 1996; 334: 1106-1115.
129. Bitton A, Dobkin PL, Edwardes MD, Sewitch MJ, Meddings JB, Rawal S, Cohen A, Vermeire S, Dufresne L, Franchimont D and Wild GE. Predicting relapse in Crohn’s disease: a biopsychosocial model. Gut 2008; 57: 1386-1392.
130. Bernstein CN, Singh S, Graff LA, Walker JR, Miller N and Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 2010; 105: 1994-2002.
131. Bonaz BL and Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013; 144: 36-49.
132. Heikkila K, Madsen IE, Nyberg ST, Fransson EI, Ahola K, Alfredsson L, Bjorner JB, Borritz M, Burr H, Dragano N, Ferrie JE, Knutsson A, Koskenvuo M, Koskinen A, Nielsen ML, Nordin M, Pejtersen JH, Pentti J, Rugulies R, Oksanen T, Shipley MJ, Suominen SB, Theorell T, Vaananen A, Vahtera J, Virtanen M, Westerlund H, Westerholm PJ, Batty GD, Singh-Manoux A and Kivimaki M. Job strain and the risk of inflammatory bowel diseases: individual-participant meta-analysis of 95,000 men and women. PLoS One 2014; 9: e88711.